ACLX Q4 2024 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M-75.8% YoY

Gross Profit

$15M100.0% margin

Operating Income

-$53M-348.2% margin

Net Income

-$47M-308.4% margin

EPS (Diluted)

$-0.88

QoQ Revenue Growth

-41.4%

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$48M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$711M

Total Liabilities

$257M

Stockholders' Equity

$455M

Cash & Equivalents

$106M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$63M	-75.8%
Gross Profit	$15M	$62M	-75.5%
Operating Income	-$53M	$15M	-454.4%
Net Income	-$47M	$20M	-337.3%